Rheumatoid Arthritis Trial, Recruiting NCT06631638 Sponsor: DePuy Orthopaedics Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT06631638
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The hip replacement surgery being performed must follow the approved uses for all devices involved.
  • The person is having their first-ever uncemented hip replacement using specific implant components (EMPHASYS cup with a CORAIL, EMPHASYS, or ACTIS stem), performed through one of three accepted surgical approaches with the patient lying on their side.
  • The person's surgery is planned to use a specific computer-assisted navigation system called VELYS Hip Navigation with CUPTIMIZE advanced.
  • The person is able to speak, read, and understand the consent documents, is willing to give consent to participate, and agrees to share their information with DePuy Synthes.
  • The person is willing and able to attend all follow-up appointments required by the study.
  • The person is willing and able to complete hip outcome questionnaires (FJS-12, EQ-5D-5L, and a Hip Evaluation form) at the times specified by the study.
  • The person is not bedridden, as determined by the treating doctor.
  • The person is at least 21 years old at the time of signing the consent form.

Who may not be able to join:

  • The person has an active infection anywhere in the body or at the hip site.
  • The person has significant muscle, nerve, or blood vessel problems in the affected leg that would make the surgery inadvisable.
  • The person has poor bone quality (such as osteoporosis) that, in the surgeon's opinion, creates a meaningful risk of the implant shifting or the bone fracturing, or that does not provide enough bone to support the implant.
  • The person has Charcot's joint disease or Paget's disease.
  • The person is pregnant or breastfeeding.
  • The person has had the opposite leg amputated.
  • The person has previously had a partial hip replacement in the hip being treated.
  • The person has taken part in a clinical trial involving an investigational drug or device within the last three months.
  • The person had their opposite hip replaced less than 6 months before the planned surgery date.
  • The person is currently involved in a personal injury lawsuit, medical-legal case, or workers' compensation claim.
  • The person has been diagnosed with a muscular condition causing severe stiffness and pain (such as fibromyalgia or polymyalgia) and is currently taking prescription medication for it.
  • The person has a medical condition where life expectancy is less than 2 years.
  • In the investigator's opinion, the person has a drug or alcohol dependency, or a psychological condition that could affect their ability to complete questionnaires or attend follow-up visits.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 610-241-3260

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
DePuy Orthopaedics
Registry
ClinicalTrials.gov
Start date
24 October 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite endpoint: Acetabular Cup Position Success at 6 Weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov